1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Minimal Change Disease: new trials by email Literature Review of Minimal Change Disease trials Research Report on Minimal Change Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS) VB119 - Minimal Change Disease, Focal Segmental Glomerulosclerosis | Phase 2 | Terminated | Tenet Medicines | 1 | 2022-05-03 | 2024-04-22 |
Glomerulosclerosis, Focal Segmental (1) · Nephrosis, Lipoid (1)
Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glomerulonephritis (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Nephritis (1) · Nephrosis (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Tenet Medicines (1)
United States (1)